Interviews with the world’s key opinion leaders in cancer

TagAML

Amir Fathi MD; ASH 2025: Paradigm Study Finds Young, Fit Adults with Acute Myeloid Leukemia Do Better with Gentler Azacitidine/Venetoclax Initial Therapy

3 months ago

Amir Fathi MD; ASH 2025: Paradigm Study Finds Young, Fit Adults with Acute Myeloid Leukemia Do Better with Gentler Azacitidine/Venetoclax Initial...

Jesse Tettero MD PhD; ASH 2025: Measurable Residual Disease Can Predict Overall Survival in Patients with Acute Myeloid Leukemia

4 months ago

Audio Journal of Oncology Podcast Jesse Tettero MD PhD; ASH 2025: Measurable Residual Disease Can Predict Overall Survival in Patients with Acute...

Single-cell RNA Sequencing Provides Comprehensive Map of Acute Myeloid Leukemia Cell States

11 months ago

An interview with: Andy Zeng, MD/PhD candidate, University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada With comment from: Hussein...

Genomic-led AML Clinical Decision Making Within Seven Days

December 31, 2019

Audio Journal of Oncology Reporting from 2018 annual meeting of the American Society of Hematology INTERVIEW WITH: John C. Byrd MD, Chief Medical...

AJO Audio Oncology

Venetoclax Pro-Apoptotic Therapy Benefits Older Patients with Acute Myeloid Leukemia

January 19, 2018

Audio Journal of Oncology Podcast Venetoclax Pro-Apoptotic Therapy Benefits Older Patients with Acute Myeloid Leukemia Play Episode Pause Episode...